| Literature DB >> 28232773 |
Esther F Myers1, Naomi Trostler1, V Varsha1, Hillary Voet1.
Abstract
This 12-month prospective randomized cluster trial of 20 dietitians in India compared usual care (UC) and evidence-based nutrition practice guideline (EBNPG) care for patients with type 2 diabetes mellitus. Baseline, 6-month, and 12-month data from 238 patients were analyzed. EBNPG implementation was evaluated using the Ottawa Model for Knowledge Transfer. EBNPG and UC groups achieved significant hemoglobin A1C improvements. EBNPG-treated participants were significantly more likely to meet low-density lipoprotein, high-density lipoprotein, and triglyceride goals at 6 or 12 months. Dietitian dropout, implementation barriers, and undetermined EBNPG intervention fidelity are limitations. Future research should assess barriers/supports and degree of EBNPG use.Entities:
Keywords: clinical nutrition; diabetes mellitus; dietetics outcomes; evidence-based guidelines; nutrition; nutrition care process
Year: 2017 PMID: 28232773 PMCID: PMC5302411 DOI: 10.1097/TIN.0000000000000089
Source DB: PubMed Journal: Top Clin Nutr ISSN: 0883-5691 Impact factor: 0.508
Figure 1.DINGS Research Design. DINGS indicates Diabetes in India Nutrition Guidelines Study; EBNPG, evidence-based nutrition practice guideline; UC, usual care.
Summary of Recommendations in EBNPGs for Persons With Type 1 and 2 Diabetes Mellitusa
| Step of Nutrition Care Process | Recommendation | Strength of Recommendation | Guideline | Comparison to Usual Care in India |
|---|---|---|---|---|
| Number and length of initial series of MNT encounters | Strong, imperative | 3-4 encounters (45-90 min) within 3-6 mo after referral | Different | |
| MNT long-term follow-up encounters | Strong, imperative | Dietitian determined, regular sessions sustained positive outcomes | Different | |
| Nutrition assessment | Nutrition assessment | Strong, imperative | Assess food intake, medication, metabolic control, anthropometric measurement, and physical activity | Usually same |
| Assessment of glycemic control | Strong, imperative | Assess glycemic control and focus on achieving target blood glucose levels | Usually same | |
| Assess relative importance of weight management | Strong, conditional (for those who are overweight or obese) | Modest weight loss may improve insulin resistance; however, long-term impact inconsistent | Usually same | |
| Nutrition intervention | Intervention options | Strong, imperative | Implement MNT selecting from a variety of interventions, education, and counseling sensitive to personal needs and based on willingness to change and ability to make changes | Varied, usually relied on nutrition education vs nutrition counseling |
| Macronutrient percentages | Strong, imperative | Macronutrients based on national dietary guidelines | Usually same | |
| Carbohydrate intake consistency | Strong, conditional (persons with medication) | Keep meal and snack carbohydrate intake consistent on a day-to-day basis | Usually same | |
| Sucrose intake | Strong, conditional (persons who choose to eat foods with sucrose) | Not more than 10%-35% of total energy substituted for other carbohydrate containing foods | Usually same | |
| Nonnutritive sweeteners | Fair, conditional (persons who choose to consume nonnutritive sweeteners) | Advise to stay less than average daily intakes; no impact on glycemic control | Different; not usually addressed | |
| GI | Fair, conditional (when GI is proposed as a method of meal planning) | Advise that GI research reports mixed results on HbA1C | Different | |
| Fiber intake and glycemia | Strong, imperative | 44- to 50-g fiber is reported to improve glycemia; however, unsure if this level is feasible | Same | |
| Fiber intake and cholesterol | Strong, imperative | 25- to 30-g fiber (emphasizing soluble) can reduce cholesterol | Same | |
| Protein intake and normal renal function | Fair, conditional (persons with normal renal function) | Maintain usual intake of 20%-25% of energy from protein | Same | |
| Blood glucose monitoring | Fair, conditional (persons on nutrition therapy alone or in combination with glucose-lowering medication) | Frequency and timing of blood glucose monitoring dependent on DM goals and therapies and incorporated into diabetes education programs | Different; not usually addressed in T2DM | |
| CVD and cardioprotective nutrition interventions | Strong, imperative | Reduction in saturated and trans fat and dietary cholesterol and interventions to reduce blood pressure | Different | |
| Diabetes and weight management | Fair, conditional | Unclear that weight loss along will improve glycemic control | Same | |
| T2DM and physical activity | Strong, conditional | 50-90 min of accumulated moderate-intensity aerobic physical activity per week as well as resistance/strength training 3 times per week | Different | |
| Coordination of care | Imperative, consensus | Coordinate care with interdisciplinary team approach | Different | |
| Monitoring and evaluation | Monitoring and evaluation | Strong, imperative | Monitor and evaluate food intake, medication, metabolic control, anthropometric measures, and physical activity | Different; many times not able to have follow-up visits to monitor |
| Evaluation of glycemic control | Consensus, imperative | Use blood glucose monitoring results to evaluate effectiveness of MNT | Different; many times not able to have follow-up visits to monitor |
Abbreviations: CVD, cardiovascular disease; DINGS, Diabetes in India Nutrition Guidelines Study; EBNPG, evidence-based nutrition practice guideline; GI, glycemic index; HbA1C, hemoglobin A1C; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MNT, medical nutrition therapy; SMBG, self-monitoring blood glucose; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; UC, usual care.
aAdapted with permission from American Dietetic Association31 and Academy of Nutrition and Dietetics.40
bSelected recommendations that apply to the DINGS population. Other recommendations not applicable to this population are carbohydrate intake and insulin dose adjustment, protein intake and nephropathy, protein intake and late-stage nephropathy, frequency of blood glucose monitoring, possible need for continuous glucose monitoring or more frequent SMBG, T1DM and physical activity, physical activity and insulin/insulin secretagogue use).
cRecommendations are rated as Strong, Fair, Weak, Consensus, or Insufficient Evidence. Strong: Good/strong evidence identified that benefits of following the recommendation exceed the harms; practitioners should generally follow the recommendation unless a clear and compelling rationale for alternative approach is present. Fair: Good/fair evidence identified that benefits of following the recommendation exceed the harms; practitioners should generally follow the recommendation but remain alert to new information and sensitive to patient preferences. Consensus: No studies are available, conclusion based on expert opinion; practitioners should be flexible in deciding whether to follow, and patient preferences should be a substantial influencing role.
dRecommendations fall into 2 categories: Imperative or conditional. Imperative recommendations are broadly applicable to the target population, whereas conditional recommendations apply only to a specific situation or population.
eComparison to Usual Care in India: Same indicates that all dietitians agreed that this was the same as their usual practice, usually same indicates that few dietitians did not indicate it was the same of their usual practice, and different indicates that all dietitians agreed that this was different from their usual care. Dietitians attempted to implement all applicable guidelines.
Comparison of Baseline Demographics for the EBNPG Group and the UC Group
| Parameter | Total | EBNPG Group | UC Group | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Min | Max | Mean ± SD | Mean ± SD | |||||
| All | 239 | 85 | 154 | ||||||
| Men | 143 (60%) | 46 (54%) | 97 (63%) | ||||||
| Women | 96 (40%) | 39 (46%) | 57 (37%) | ||||||
| Age, y | 219 | 46.3 ± 9.5 | 25 | 69 | 68 | 43.6 ± 9.3 | 151 | 47.6 ± 9.4 | .004 |
| Height, cm | 170 | 162.4 ± 9.4 | 140 | 180 | 51 | 161.0 ± 9.8 | 119 | 163.0 ± 9.3 | .20 |
| Weight, kg | 170 | 70.4 ± 12.9 | 45 | 116 | 51 | 69.3 ± 10.2 | 119 | 70.9 ± 14.0 | .43 |
| Body mass index | 170 | 26.6 ± 4.0 | 20 | 43 | 51 | 26.8 ± 3.2 | 119 | 26.6 ± 4.3 | .79 |
| HbA1C | 237 | 8.8 ± 2.4 | 4.6 | 16.0 | 84 | 8.7 ± 2.3 | 153 | 8.9 ± 2.5 | .63 |
| Total cholesterol | 238 | 186.2 ± 40.8 | 75 | 308 | 84 | 185.5 ± 42.9 | 154 | 186.6 ± 39.7 | .85 |
| LDL cholesterol | 238 | 113.4 ± 31.6 | 18 | 237 | 84 | 113.6 ± 31.7 | 154 | 113.3 ± 31.6 | .95 |
| HDL cholesterol | 238 | 39.1 ± 10.0 | 19 | 88 | 84 | 37.9 ± 8.8 | 154 | 39.8 ± 10.5 | .14 |
| Triglycerides | 238 | 191.5 ± 210.3 | 44 | 2714 | 84 | 205.8 ± 290.1 | 154 | 183.7 ± 150.7 | .32 |
Abbreviations: EBNPG, evidence-based nutrition practice guideline; HbA1C, hemoglobin A1C; HDL, high-density lipoprotein; LDL, low-density lipoprotein; UC, usual care.
aP values were calculated using 2-sample t test.
Comparing Average Change From Baseline at 6 Months and 12 Months for the ENBPG Group vs the UC Group
| Parameter and Measurement Period | EBNPG Group | UC Group | |||
|---|---|---|---|---|---|
| Mean ± SD Change From Baseline | Mean ± SD Change From Baseline | ||||
| HbA1C, mg/dL | |||||
| 6 mo | 37 | −1.69 ± 1.89 | 81 | −1.30 ± 2.44 | .39 |
| 12 mo | 35 | −1.03 ± 1.94 | 77 | −1.02 ± 2.49 | .99 |
| Body mass index | |||||
| 6 mo | 23 | −0.78 ± 1.45 | 45 | −0.27 ± 1.58 | .20 |
| 12 mo | 17 | −0.95 ± 1.87 | 42 | −0.52 ± 1.95 | .43 |
| Total cholesterol, mg/dL | |||||
| 6 mo | 37 | −11.0 ± 40.9 | 81 | −6.0 ± 38.6 | .51 |
| 12 mo | 35 | −14.9 ± 30.0 | 77 | −6.7 ± 36.3 | .25 |
| LDL cholesterol, mg/dL | |||||
| 6 mo | 37 | −0.8 ± 30 | 81 | −4.5 ± 31 | .54 |
| 12 mo | 35 | −11 ± 20 | 77 | −5.6 ± 30 | .25 |
| HDL cholesterol, mg/dL | |||||
| 6 mo | 37 | +2.0 ± 4.3 | 81 | +0.7 ± 6.5 | .18 |
| 12 mo | 35 | +1.6 ± 4.9 | 77 | +0.2 ± 9.6 | .30 |
| Triglyceride, mg/dL | |||||
| 6 mo | 37 | −87 ± 348 | 81 | −3 ± 89 | .01 |
| 12 mo | 35 | −74 ± 224 | 77 | −4 ± 85 | .01 |
Abbreviations: EBNPG, evidence-based nutrition practice guideline; HbA1C, hemoglobin A1C; HDL, high-density lipoprotein; LDL, low-density lipoprotein; UC, usual care.
aSignificance established after log transformation with 2-sample t test.
bP ≤ .001 significance of change from baseline within group using paired-samples t test.
cP ≤ .01 significance of change from baseline within group using paired-samples t test.
dP ≤ .05 significance of change from baseline within group using paired-samples t test.
Percentage of Patients at Expected Outcome or Ideal-Goal Value34 at 12 Months
| Parameter | Group | n | Met Expected Outcome or Ideal or Goal Value, % | Not Meeting Expected Outcome or Ideal or Goal Value, % | Significance of Difference Between Groups |
|---|---|---|---|---|---|
| HbA1C | EBNPG | 35 | 40.0 | 60.0 | .52 |
| UC | 77 | 33.8 | 66.2 | ||
| Total cholesterol | EBNPG | 35 | 74.3 | 25.7 | .11 |
| UC | 77 | 58.4 | 41.6 | ||
| LDL cholesterol | EBNPG | 35 | 65.7 | 34.3 | .003 |
| UC | 77 | 36.4 | 63.6 | ||
| HDL cholesterol | EBNPG | 35 | 74.3 | 25.7 | .047 |
| UC | 77 | 54.6 | 45.5 | ||
| Triglycerides | EBNPG | 35 | 82.9 | 17.1 | .003 |
| UC | 77 | 53.3 | 46.8 |
Abbreviations: EBNPG, evidence-based nutrition practice guideline; HbA1C, hemoglobin A1C; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NS, not significant; UC, usual care.
aExpected Outcomes or Ideal-Goal values-goals were defined by 2011 Diabetes Mellitus Toolkit (28) used in the research: HbA1C, <7 mg/dl; LDL cholesterol, <100 mg/dL; total cholesterol, any decrease from baseline; HDL, no change or increase; triglyceride, decreased or no change. (Note. 2015 Guidelines have been published, but the 2011 Toolkit is the most current toolkit available at www.eatright.org.)
bSignificance calculated using chi-square tests.
cSignificance of P ≤ .01.
dSignificance of P ≤ .05.
Figure 2.DINGS model of adopting innovations. DINGS indicates Diabetes in India Nutrition Guidelines Study; EBNPG, evidence-based nutrition practice guideline; NCP, Nutrition Care Process; NCPT, Nutrition Care Process and Terminology; SMBG, self-monitoring blood glucose. Adapted from the “Ottawa Model of Research Use: A Framework for Adopting Innovations” with permission from the National Collaborating Centre for Methods and Tools5 (available at http://www.nccmt.ca/registry/view/eng/65.html. Copyright © 2006 The Alliance for Continuing Medical Education, the Society for Medical Education, the Society for Academic Continuing Medical Education, and the Council on CME, Association for Hospital Medical Education).